A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine - PIONEER-PEDS1 - Eli Lilly and CompanySee more
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine - REBUILD-1 - Eli Lilly and CompanySee more
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine - REBUILD-2 - Eli Lilly and CompanySee more
Breast Cancer
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer - ASCENT-03 - Gilead SciencesSee more
Non-Hodgkin Lymphoma
Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma - LOTIS 5 - ADC Therapeutics S.A.See more
